This week, the federal government announced it would begin processing dozens of pending applications for the “steps necessary to improve access to marijuana research.”
Additionally, companies hoping to obtain U.S. Drug Enforcement Agency Registration for a federal bulk manufacturer licenses to cultivate cannabis for scientific research as well as for manufacturing FDA- approved pharmaceuticals, are seemingly once step closer, with an arsenal of caveats.
“I am pleased that DEA is moving forward with its review of applications for those who seek to grow marijuana legally to support research,” said Attorney General William P. Barr, in a statement released by the Department of Justice’s (DOJ) Office of Public Affairs. “The Department of Justice will continue to work with our colleagues at the Department of Health and Human Services and across the Administration to improve research opportunities wherever we can.”
– Read the entire article at Forbes.